Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Liat Nadav Dagan"'
Autor:
Benjamin Geiger, Ben-Zion Katz, Eytan Domany, Elizabeth Naparstek, Nili Dezorella, Tal Shay, Liat Nadav-Dagan
Supplementary Data from Adhesive Interactions Regulate Transcriptional Diversity in Malignant B Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4571e8da3751eab467b57fb84aa53496
https://doi.org/10.1158/1541-7786.22519207
https://doi.org/10.1158/1541-7786.22519207
Autor:
Izidore S. Lossos, Liat Nadav Dagan, Klaus Rajewsky, Shruti Bhatt, Xiaoyu Jiang, Elena Cubedo
Publikováno v:
Blood. 119:513-520
HGAL, a prognostic biomarker in patients with diffuse large B-cell lymphoma and classic Hodgkin lymphoma, inhibits lymphocyte and lymphoma cell motility by activating the RhoA signaling cascade and interacting with actin and myosin proteins. Although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae06e897c36d95ea30bd0fd5e7a0ab39
https://doi.org/10.1182/blood-2011-08-370536
https://doi.org/10.1182/blood-2011-08-370536
Autor:
Liat Nadav-Dagan, Ben-Zion Katz
Publikováno v:
Leukemia & Lymphoma. 52:2050-2056
The generation of cellular diversity is considered a key factor in the development of cancer. The research of B-cell malignancies provides a unique opportunity to study the origin, regulation, and physiological significance of diversification mechani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b820a0ca6d9f89d88a7783521547929f
https://doi.org/10.3109/10428194.2011.587564
https://doi.org/10.3109/10428194.2011.587564
Autor:
Elizabeth Naparstek, Liat Nadav-Dagan, Ben-Zion Katz, Eytan Domany, Nili Dezorella, Benjamin Geiger, Tal Shay
Publikováno v:
Molecular Cancer Research. 8:482-493
The genetic profiling of B-cell malignancies is rapidly expanding, providing important information on the tumorigenic potential, response to treatment, and clinical outcome of these diseases. However, the relative contributions of inherent gene expre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8a2f31c58de9deca76a98def0e7d05b
https://doi.org/10.1158/1541-7786.mcr-09-0182
https://doi.org/10.1158/1541-7786.mcr-09-0182
Publikováno v:
Blood. 116:464-464
Abstract 464 HGAL is a germinal center (GC)-specific gene that inhibits lymphocyte and lymphoma cell motility and whose expression predicts improved survival of patients with diffuse large B-cell lymphoma (DLBCL) and classical Hodgkin lymphoma (cHL).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53f233fbfba41269fc5cf40a5c0eb6bf
https://doi.org/10.1182/blood.v116.21.464.464
https://doi.org/10.1182/blood.v116.21.464.464
Autor:
Oliver W. Press, Andrew M. Evens, Nancy L. Bartlett, Liat Nadav Dagan, Ramsey Abdallah, Linda M. Parker, Francisco J. Hernandez-Ilizaliturri, Stavroula Otis, Leo I. Gordon, Jessica L. Yarber, Barrett K. Robinson, Christopher R. Flowers, Ranjana H. Advani, Jose Sandoval, Julie M. Vose, John P. Leonard, Kelley V. Foyil, Izidore S. Lossos, Thomas M. Habermann, Aimee R. Kroll-Desrosiers, Kristie A. Blum
Publikováno v:
Scopus-Elsevier
Purpose Lymphoma is the fourth most frequent cancer in pregnancy; however, current clinical practice is based largely on small series and case reports. Patients and Methods In a multicenter retrospective analysis, we examined treatment, complications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd0c85b7fccb25a9c8260368e65a8db1
http://www.scopus.com/inward/record.url?eid=2-s2.0-84891950541&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84891950541&partnerID=MN8TOARS
Autor:
Evens AM; Andrew M. Evens, Tufts University School of Medicine, Boston; Aimee Kroll-Desrosiers, University of Massachusetts Medical School, Worcester, MA; Ranjana Advani and Stavroula Otis, Stanford University Medical Center, Stanford, CA; Oliver W. Press and Linda M. Parker, Fred Hutchinson Cancer Research Center, Seattle, WA; Izidore S. Lossos, Liat Nadav Dagan, and Jose Sandoval, University of Miami School of Medicine, Miami, FL; Julie M. Vose, University of Nebraska Medical Center, Omaha, NE; Francisco J. Hernandez-Ilizaliturri, Roswell Park Cancer Institute, Buffalo; Ramsey Abdallah and John P. Leonard, Weill Cornell Medical College, New York, NY; Barrett K. Robinson, Indiana University School of Medicine, Indianapolis, IN; Jessica L. Yarber and Leo I. Gordon, Northwestern University Feinberg School of Medicine, Chicago, IL; Kristie A. Blum, The Ohio State University, Columbus, OH; Christopher R. Flowers, Emory University, Atlanta, GA; Thomas M. Habermann, Mayo Clinic, Rochester, MN; and Nancy L. Bartlett, Washington University School of Medicine, St. Louis, MO., Advani R, Press OW, Lossos IS, Vose JM, Hernandez-Ilizaliturri FJ, Robinson BK, Otis S, Nadav Dagan L, Abdallah R, Kroll-Desrosiers A, Yarber JL, Sandoval J, Foyil K, Parker LM, Gordon LI, Blum KA, Flowers CR, Leonard JP, Habermann TM, Bartlett NL
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2013 Nov 10; Vol. 31 (32), pp. 4132-9. Date of Electronic Publication: 2013 Sep 16.